Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 3—March 2006
Letter

Rickettsia slovaca Infection, France

Frédérique Gouriet*, Jean-Marc Rolain*, and Didier Raoult*Comments to Author 
Author affiliations: *Université de la Méditerranée, Marseille, France

Main Article

Table A1

Laboratory results for 14 patients with Rickettsia slovaca infection*

Patient MIF assay
Culture
PCR
Acute-phase serum† Convalescent-phase serum* WB Cross-adsorption Skin biopsy Tick Skin biopsy Tick Acute phase serum
1 256/0 256/0 + R. slovaca NA NA
2 0/32 NA + R. slovaca NA R. slovaca NA
3 0/0 0/0 + R. slovaca R. slovaca NA R. slovaca NA
4 0/0 0/0 NA NA R. slovaca NA R. slovaca NA
5 0/0 32/32 + R. slovaca NA NA NA NA R. slovaca
6 0/32 0/32 + R. slovaca NA NA NA NA
7 0/0 64/64 NA NA NA R. slovaca NA R. slovaca
8 0/0 NA + R. slovaca NA NA
9 32/32 NA + R. slovaca NA NA
10 0/0 NA NA NA NA NA NA R. slovaca
11 0/0 NA NA NA NA NA NA NA
12 64/0 64/0 + R. slovaca R. slovaca
13 0/128 NA + R. slovaca NA NA NA NA
14 256/128 NA + R. slovaca NA NA NA NA

*MIF, microimmunofluorescence; WB, Western blot; PCR, polymerase chain reaction; NA, not available.
†Antibody titers are immunoglobulin G (IgG)/IgM against R. slovaca.

Main Article

Page created: January 27, 2012
Page updated: January 27, 2012
Page reviewed: January 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external